The third-largest medtech acquisition of the year happened with little fanfare this week. Coloplast spent €2.2bn ($2.5bn) on Atos Medical, a maker of devices for tracheostomy and laryngectomy patients, knocking ICU Medical’s purchase of Smiths Group’s medical business into fourth place. The Sweden-based Atos occupies more than 80% of the laryngectomy market, according to Coloplast, with sales last year of SEK2.2bn ($253m). Coloplast, which had a difficult 2020 as the pandemic hit its hospital business, has recovered surprisingly well, with its stock up 23% year to date. Its sales are forecast to grow at a respectable annual rate of 8% to 2026, Evaluate Medtech data show; perhaps, with the inclusion of Atos’s technology, they will grow faster still.
| Top 5 medtech M&A of 2021 | ||||
|---|---|---|---|---|
| Announcement date | Acquirer | Target | Value ($bn) | Focus |
| Sep 1 | Baxter International | Hill-Rom | 10.5 | General hospital & healthcare supply; healthcare IT |
| Jan 12 | Steris | Cantel Medical | 4.6 | Endoscopy; general & plastic surgery; nephrology |
| Nov 8 | Coloplast | Atos Medical | 2.5 | Ear, nose & throat; general hospital & healthcare supply |
| Sep 8 | ICU Medical | Smiths Medical (subunit of Smiths Group) | 2.4 | Anaesthesia & respiratory; patient monitoring |
| Mar 12 | Roche | Genmark Diagnostics | 1.8 | In vitro diagnostics |
| Note: excludes Spac deals. Source: Evaluate Medtech & company release. https://www.evaluate.com/vantage/articles/news/snippets/coloplast-goes-throat | ||||
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.